We see you are visiting from an Internet Explorer browser. Due to the deprecation of Internet Explorer and for security reasons, the PSG site is not supported in Internet Explorer. For the best experience, please use an alternate browser.

DoseSpot provides ePrescription software enabling clinicians to electronically write and transmit prescriptions to pharmacies.

Psg portfolio Dose Spot background

DoseSpot provides ePrescription software enabling clinicians to electronically write and transmit prescriptions to pharmacies. The solution is Surescripts certified and eases the administrative burden of the prescription life cycle by integrating with EHRs. Clinicians can prescribe medication without leaving their core workflows and remain compliant with state-specific and federal regulations for prescribing medication and controlled substances. Founded in 2009 and based in Dedham, MA, DoseSpot serves more than 300 healthcare clients ranging from digital/telehealth firms, hospice pharmacies, and EHR and practice management software companies to dental services.

Year Invested
2021
Location
Dedham, MA
Website
dosespot.com
"At DoseSpot, our culture revolves around serving as the most trusted partner in our industry. Our clients and end users are responsible for the most important thing: delivering care to those who need it, when they need it. It’s our job to make this easier, and in many cases possible. This mission permeates everything we do at DoseSpot."
— Josh Weiner, CEO of DoseSpot

This statement is provided by an executive of a portfolio company of a PSG fund. PSG has not provided cash or other compensation in exchange for receiving this statement. Any discretion PSG exercises in the determination of the compensation of its portfolio company executives, or other benefits provided to such executives, is not influenced by whether such executive has provided a favorable statement. Nevertheless, the fact that any statements have been provided by individuals whose compensation PSG exercises a certain level of control over, or who may receive certain benefits from PSG, may incentivize such individuals to provide favorable evaluations of their experiences working with PSG. The executive is not an investor in strategies sponsored by PSG.

Did you know?

DoseSpot has more than 200K registered users on our solution each month.

Next Company
Psg portfolio element451 logo

Element451 is a leading AI-first student engagement platform transforming higher education recruitment and retention